Chemo-Pharma Laboratories Ltd.

View in App
82.95 +0.45 ▲0.6%

23 April 2024, 04:01:00 PM
Volume: 1,664

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.thechemopharmalaboratoriesltd.com
Market Cap 12.44 Cr.
Enterprise Value(EV) 6.46 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 8.97 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 9.25 Trailing Twelve Months Ending 2023-12
Industry PE 41.03 Trailing Twelve Months Ending 2023-12
Book Value / Share 87.30 Trailing Twelve Months Ending 2023-12
Price to Book Value 0.95 Calculated using Price: 82.95
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.15 Cr. 1,500,000 Shares
FaceValue 10
About Chemo-Pharma Laboratories Ltd.
Chemo Pharma Laboratories has been an established company since 1942 and has been making pharmaceuticals and also had diversified into bulk drugs. However, due to increase in competition and flow of new drugs, the company had to dispose the business and pay all its liabilities and dues.

Chemo-Pharma Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Chemo-Pharma Laboratories Ltd. Performance

View details >>
1 Day
+0.55%
1 Week
+4.87%
1 Month
+37.63%
3 Month
+10.60%
6 Month
+144.98%
1 Year
+113.24%
2 Year
+96.10%
5 Year
+773.16%
10 Year
+284.03%

Chemo-Pharma Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 5.61 4.15 60.99 1 2.02 3.94 2.3 4.97 0.41
Return on Capital Employed (%) 7.52 5.96 68.41 7.54 2.5 4.69 2.86 3.24 0.74
Return on Assets (%) 5.2 3.9 57.64 0.96 2 3.88 2.27 4.99 0.42

Chemo-Pharma Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 5 5 10 10 10 11 11 12 12 12
Non Curr. Liab. 0 0 0 0 0 0
Curr. Liab. 0 0 1 0 0 0 0 0 0 0
Minority Int.
Equity & Liab. 6 6 11 10 10 11 11 11 11 12
Non Curr. Assets 3 3 2 2 2 2 0 5 5 6
Curr. Assets 2 2 9 9 9 9 11 6 6 6
Misc. Exp. not W/O
Total Assets 6 6 11 10 10 11 11 11 11 12

Chemo-Pharma Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales
Other Income 1 0 6 1 1 1 1 1 1 1
Total Income 1 0 6 1 1 1 1 1 1 1
Total Expenditure 0 0 0 0 -1 0 0 -1 -1 0
PBIDT 0 0 5 1 0 1 0 0 0 1
Interest 0
Depreciation 0 0 0 0 0
Taxation 0 0 -1 -1 0 0 0 0 0 0
Exceptional Items
PAT 0 0 5 0 0 0 0 1 0 1
Adjusted EPS 2 1 31 1 1 3 2 4 0 9

Chemo-Pharma Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 6 -2 -5 5 0 0 -1
Cash Fr. Inv. 0 0 0 1 1 1 1 0 1 1
Cash Fr. Finan. -1 1 2 -2 0
Net Change 0 0 0 6 1 -5 6 1 -1 0
Cash & Cash Eqvt 0 0 0 7 8 3 9 2 1 1

Chemo-Pharma Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 27.89 27.89 27.89 27.89 27.89 27.89 27.89 27.89 27.89
Public 72.11 72.11 72.11 72.11 72.11 72.11 72.11 72.11 72.11
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Chemo-Pharma Laboratories Ltd. Announcements

View details >>
Tue, 23 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulation 2015
Thu, 11 Apr 2024
Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended March 31 2024
We hereby submit Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations 2015 for the year ended March 31 2024.
Fri, 05 Apr 2024
Compliance Certificate Pursuant To Regulation 7(3) Of Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended 31St March 2024
Compliance Certificate Pursuant to Regulation 7(3) of SEBI (LODR) Regulations 2015 for the Financial Year Ended 31st March 2024.

Chemo-Pharma Laboratories Ltd. Technical Scans

View details >>
Tue, 23 Apr 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone

Chemo-Pharma Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,001.33 1,484.65 -3.6%
Cipla Ltd. 108,812.62 1,346.70 -0.6%
Divi's Laboratories Ltd. 100,075.02 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. 99,325.26 5,952.10 -1.1%
Zydus Lifesciences Ltd. 96,553.18 959.45 0.0%
Mankind Pharma Ltd. 95,896.87 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. 89,224.37 2,637.40 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 39.97 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 29.34 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 72.36 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.47 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.52 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.72 2,637.40 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.71 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 4.20 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.68 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.79 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.48 2,637.40 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,637.40 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,637.40 +1.8%

Chemo-Pharma Laboratories Ltd. FAQ's

What is Chemo Pharma Labs share price?
Can I buy Chemo Pharma Labs shares now?
What is the Market Cap of Chemo Pharma Labs?
What are the key metrics to analyse Chemo Pharma Labs?
What is the 52 Week High and Low of Chemo Pharma Labs?
What is the trend of Chemo Pharma Labs share price?